Winston Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 16-01-2025
- Paid Up Capital ₹ 5.11 Cr
as on 16-01-2025
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.92 Cr
as on 16-01-2025
About Winston Pharmaceuticals
- CIN/LLPIN
U24231MH1996PLC360820
- Company No.
020204
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Jun 1996
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Winston Pharmaceuticals Limited offer?
Winston Pharmaceuticals Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Anti Infective Drugs & Medicines, Malaria Medicine, Antibiotic Injection, Health Conditions, Liver Care, Vitamins & Supplements, Vitamins A-Z, Pain Relief.
Who are the key members and board of directors at Winston Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Sharma  | Director | 26-Feb-2015 | Current |
| Rajesh Kumar | Director | 24-Dec-2020 | Current |
| Ranjana Sharma | Director | 12-Jan-2018 | Current |
| Hitesh Bhandari | Director | 24-Dec-2020 | Current |
Financial Performance of Winston Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Winston Pharmaceuticals?
Unlock access to Winston Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rv Lifesciences LimitedActive 33 years 3 monthsRajesh Kumar, Rajiv Sharma and 2 more are mutual person
Charges (Loans)
₹0
₹6.92 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of India : 2.71 Cr
- Hdfc Bank Limited : 1.98 Cr
- Others : 1.76 Cr
- Corporation Bank : 0.25 Cr
- Punjab National Bank : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2017 | Others | ₹1.76 Cr | Satisfied |
| 06 Jun 2016 | Hdfc Bank Limited | ₹1.98 Cr | Satisfied |
| 30 Sep 2014 | Union Bank Of India | ₹3.00 M | Satisfied |
| 26 Dec 2012 | Union Bank Of India | ₹1.64 M | Satisfied |
| 25 Jan 2012 | Union Bank Of India | ₹1.00 M | Satisfied |
How Many Employees Work at Winston Pharmaceuticals?
Unlock and access historical data on people associated with Winston Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winston Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winston Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
